CD1D and lymphoma: In particular, iNKT cells, that are CD1d-restricted cells, can induce cell death of chronic lymphocytic leukemia cells after stimulation with alphaGalCer [47], and can trigger secondary anti-lymphoma response in murine models of lymphoma [48].